Bone PET vs Bone Scintigraphy: When Each Is Used

For decades, bone scintigraphy with Tc-99m methylene diphosphonate (the standard "bone scan") was the workhorse for detecting bone metastases. PET-based bone imaging (Na-F PET or FDG PET) has emerged as a more sensitive alternative. The two share the goal but differ in technology, image quality, sensitivity, and cost. This guide compares them.

Two Bone Imaging Workhorses

The two main bone imaging options:

Feature	Bone scintigraphy (Tc-99m MDP)	Na-F PET-CT
Tracer	Tc-99m methylene diphosphonate	F-18 sodium fluoride
Imaging modality	SPECT or planar	PET-CT
Spatial resolution	~10 mm	~5 mm
Sensitivity for bone metastases	70–85%	90–95%
Image acquisition time	3–4 hours	90 minutes
Cost	$400–1,500	$2,500–4,500
Radiation dose	4–6 mSv	6–8 mSv
Availability	Universal	Limited to PET centers

Na-F PET is more sensitive and produces better images but is significantly more expensive and less universally available.

Tc-99m Methylene Diphosphonate (Bone Scan)

The traditional bone scan:

• IV injection of Tc-99m MDP
• 2–3 hour delay (tracer binds to bone with high osteoblastic activity)
• Whole-body planar imaging or SPECT
• "Hot spots" indicate areas of increased bone turnover (metastases, fracture, infection, arthritis)

Strengths:
- Universally available
- Established cost and reimbursement
- Comprehensive whole-body coverage
- Sensitive for sclerotic (bone-forming) metastases

Limitations:
- Lower spatial resolution than PET
- Limited sensitivity for lytic (bone-destroying) metastases
- Long imaging time (2–4 hour clinic visit)

Na-F PET: Newer Bone-Specific Tracer

F-18 sodium fluoride PET:

• IV injection of F-18 Na-F
• 60-minute uptake phase
• PET-CT whole-body acquisition (20–30 minutes)
• "Hot spots" indicate areas of increased bone turnover with higher resolution

Advantages over Tc-99m bone scan:
- Higher sensitivity for both lytic and sclerotic bone metastases
- Better spatial resolution
- Shorter total exam time
- CT correlation included

Disadvantages:
- Higher cost
- Limited availability outside major PET centers
- Higher radiation dose

FDG PET for Bone Metastases

FDG PET also detects bone metastases:

• Sensitivity depends on the primary tumor type
• High sensitivity for FDG-avid cancers in marrow (lymphoma, lung, breast, esophageal)
• Lower sensitivity for less FDG-avid bone metastases (prostate, renal cell, well-differentiated NET)
• Detects soft tissue mass component of bone lesions (a unique advantage)

For most cancer staging that includes bone assessment, FDG PET-CT is the default imaging — Na-F PET is reserved for cases where FDG fails or bone-only imaging is needed.

For specialized bone imaging in your cancer type, our team can help.

Sensitivity by Cancer Type

Comparative sensitivity for bone metastases:

Primary cancer	Best modality
Prostate adenocarcinoma	PSMA PET (highest), then Na-F PET, then bone scan
Breast cancer	FDG PET-CT (most common) or Na-F PET
Lung cancer	FDG PET-CT
Lymphoma	FDG PET-CT
Renal cell carcinoma	Contrast CT/MRI; FDG and Na-F PET less helpful
Multiple myeloma	MRI of spine + skeletal survey; FDG PET-CT add-on
Thyroid carcinoma	Radioactive iodine scan (I-131) + FDG PET if dedifferentiated
Neuroendocrine tumor	DOTATATE PET

The choice of bone imaging follows the choice of cancer-specific tracer.

Cost and Availability

Cash prices across destinations:

Imaging	US (cash)	UK (private)	Mainland China
Bone scintigraphy (Tc-99m)	$400–1,500	£300–600	¥1,500–3,000
Na-F PET-CT	$2,500–4,500	£1,500–2,500	¥4,500–7,500
FDG PET-CT (whole-body, includes bone)	$3,500–6,500	£1,500–2,500	¥6,500–9,000

For most oncology patients, whole-body FDG PET-CT serves as a comprehensive evaluation including bone — Na-F or bone scintigraphy are added only for specific scenarios.

Choosing Between Them

The clinical decision:

• Standard cancer staging with FDG-avid primary: FDG PET-CT (includes bone evaluation)
• Prostate cancer staging or recurrence: PSMA PET-CT (much more sensitive for bone than Na-F or FDG)
• Castration-resistant prostate with dedifferentiation suspected: FDG PET-CT (for aggressive disease) + PSMA PET-CT
• Symptomatic bone pain in known cancer: site-specific MRI of the symptomatic area is often more useful than whole-body imaging
• Cost-constrained workup with no FDG indication: Tc-99m bone scan remains adequate
• Research or specialized academic center: Na-F PET when available

Need Help Booking?

SinoCareLink can pre-book the appropriate bone imaging (Tc-99m scan, Na-F PET, FDG PET, or PSMA PET) at a top Chinese hospital, translate reports into English, and arrange airport pickup. Contact us for a free consultation.